{"id":340664,"date":"2025-08-20T12:16:10","date_gmt":"2025-08-20T12:16:10","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-madrigal-pharmaceuticals\/"},"modified":"2025-08-20T12:16:10","modified_gmt":"2025-08-20T12:16:10","slug":"how-to-buy-madrigal-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","title":{"rendered":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340664","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Madrigal Pharmaceuticals, Inc. (MDGL) hisseleri nas\u0131l al\u0131n\u0131r ve MDGL hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel fiyat, riskler, f\u0131rsatlar ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejilerini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Madrigal Pharmaceuticals, Inc. (MDGL) hisseleri nas\u0131l al\u0131n\u0131r ve MDGL hissesine nas\u0131l yat\u0131r\u0131m yap\u0131l\u0131r \u00f6\u011frenin. G\u00fcncel fiyat, riskler, f\u0131rsatlar ve 2025 i\u00e7in ad\u0131m ad\u0131m yat\u0131r\u0131m stratejilerini ke\u015ffedin."},"intro":"Karaci\u011fer hastal\u0131klar\u0131 tedavisinin gelece\u011fine yat\u0131r\u0131m yapmaya haz\u0131r m\u0131s\u0131n\u0131z? Madrigal Pharmaceuticals, \u00e7\u0131\u011f\u0131r a\u00e7an ilac\u0131 Rezdiffra ile MASH tedavisinde devrim yarat\u0131yor. Bu biyoteknoloji \u00f6nc\u00fcs\u00fc patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeli sunuyor\u2014ancak \u00f6nemli riskler de ta\u015f\u0131yor. MDGL'nin portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve nas\u0131l hareket edece\u011finizi birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Karaci\u011fer hastal\u0131klar\u0131 tedavisinin gelece\u011fine yat\u0131r\u0131m yapmaya haz\u0131r m\u0131s\u0131n\u0131z? Madrigal Pharmaceuticals, \u00e7\u0131\u011f\u0131r a\u00e7an ilac\u0131 Rezdiffra ile MASH tedavisinde devrim yarat\u0131yor. Bu biyoteknoloji \u00f6nc\u00fcs\u00fc patlay\u0131c\u0131 b\u00fcy\u00fcme potansiyeli sunuyor\u2014ancak \u00f6nemli riskler de ta\u015f\u0131yor. MDGL'nin portf\u00f6y\u00fcn\u00fczde olup olmamas\u0131 gerekti\u011fini ve nas\u0131l hareket edece\u011finizi birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 MDGL Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla Madrigal Pharmaceuticals (MDGL) <strong>302,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu biyoteknoloji harikas\u0131n\u0131 izleyen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir an. Ancak takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle \u00e7ok \u00f6nemli. \u00c7\u00fcnk\u00fc MDGL, 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar b\u00fcy\u00fck etkiler yaratm\u0131\u015ft\u0131r.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 MDGL Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>5 A\u011fustos 2025'teki son kazan\u00e7 raporu piyasada \u015fok etkisi yaratt\u0131. \u015eirket, <a href=\"https:\/\/www.nasdaq.com\/articles\/madrigal-mdgl-q2-revenue-soars-1313\">2. \u00e7eyrek gelirinin y\u0131ll\u0131k bazda %1.313 artarak<\/a> 212,8 milyon dolara ula\u015ft\u0131\u011f\u0131n\u0131 bildirdi ve tahminleri %31,3 a\u015farak ezdi. Hisse senedi, \u00f6nceki aylarda 275-302 $ aral\u0131\u011f\u0131ndan A\u011fustos ortas\u0131nda neredeyse 370 $ seviyesine kadar dramatik bir ivme kazand\u0131.<\/p> <p>Son haber olaylar\u0131n\u0131n MDGL \u00fczerindeki etkileri \u015f\u00f6yle:<\/p> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Etkisi<\/th><th>S\u00fcre<\/th><\/tr> <\/thead> <tbody> <tr><td>17 Temmuz 2025<\/td><td>Yeni patent korumas\u0131<\/td><td>%11 art\u0131\u015f<\/td><td>Tek g\u00fcn<\/td><\/tr> <tr><td>5 A\u011fustos 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131<\/td><td>%34 art\u0131\u015f<\/td><td>2 hafta<\/td><\/tr> <tr><td>20 Haziran 2025<\/td><td>Olumlu CHMP g\u00f6r\u00fc\u015f\u00fc<\/td><td>%15 art\u0131\u015f<\/td><td>3 g\u00fcn<\/td><\/tr> <tr><td>10 May\u0131s 2025<\/td><td>Klinik deneme verileri<\/td><td>%8 art\u0131\u015f<\/td><td>1 hafta<\/td><\/tr> <\/tbody> <\/table> <p>Desen a\u00e7\u0131k: olumlu d\u00fczenleyici ve klinik haberler patlay\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc potansiyel yarat\u0131yor. Ancak unutmay\u0131n\u2014biyoteknoloji hisseleri olumsuz geli\u015fmelerde ayn\u0131 h\u0131zla d\u00fc\u015febilir.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Heyecan Dolu Dalgalanmalar<\/h2> <p>Madrigal Pharmaceuticals son alt\u0131 ayda nefes kesici bir performans sergiledi:<\/p> <p><strong>\u015eubat 2025<\/strong>: 202-220 $ (tatil sonras\u0131 konsolidasyon)<br\/> <strong>Mart 2025<\/strong>: 240-260 $ (Avrupa d\u00fczenleyici ilerlemesi)<br\/> <strong>May\u0131s 2025<\/strong>: 275 $ (istikrarl\u0131 y\u00fckseli\u015f)<br\/> <strong>Temmuz 2025<\/strong>: 302 $ (patent haberlerinin etkisi)<br\/> <strong>A\u011fustos 2025<\/strong>: 370 $ zirve (kazan\u00e7 patlamas\u0131)<\/p> <p>Bu, \u015eubat diplerinden A\u011fustos zirvelerine <strong>%75'ten fazla kazan\u00e7<\/strong> demek! Hisse, dramatik dalgalanmalarla <a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDGL\/\">%12,08 volatilite<\/a> g\u00f6sterdi ve yat\u0131r\u0131mc\u0131lara hem f\u0131rsatlar hem de stres yaratt\u0131.<\/p> <p>Bu b\u00fcy\u00fck y\u00fckseli\u015fin nedenleri?<\/p> <ul> <li>Rezdiffra'n\u0131n FDA onayl\u0131 ilk MASH tedavisi olmas\u0131<\/li> <li>Haziran 2025 itibar\u0131yla 23.000'den fazla hastan\u0131n tedavi g\u00f6rmesi<\/li> <li>Avrupa geni\u015flemesinin h\u0131zl\u0131 ilerlemesi<\/li> <li>2045 y\u0131l\u0131na kadar yeni patent korumas\u0131<\/li> <\/ul> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Mevcut analist projeksiyonlar\u0131 ve \u015firketin seyri g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, gelecekte \u015funlar olabilir:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 350-400 $ (ticari yay\u0131l\u0131m ba\u015far\u0131s\u0131n\u0131n devam\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br\/> <strong>2026<\/strong>: 450-550 $ (Avrupa pazar penetrasyonunun h\u0131zlanmas\u0131)<br\/> <strong>2028<\/strong>: 700-900 $ (k\u00fcresel geni\u015fleme ve yeni \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri)<br\/> <strong>2030<\/strong>: 1.200+ $ (karaci\u011fer hastal\u0131klar\u0131 tedavisinde pazar liderli\u011fi)<\/p> <p><a href=\"https:\/\/stockanalysis.com\/stocks\/mdgl\/forecast\/\">Analist konsens\u00fcs\u00fc<\/a> \"G\u00fc\u00e7l\u00fc Al\" derecesiyle olduk\u00e7a olumlu ve ortalama fiyat hedefi 439,71 $ seviyesinde. Ancak baz\u0131 modeller daha temkinli hedefler olan 229-275 $ aral\u0131\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor, bu da biyoteknoloji de\u011ferlemelerindeki a\u015f\u0131r\u0131 belirsizli\u011fi g\u00f6steriyor.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>FDA d\u00fczenleyici riski<\/strong>: Onaylarda ya\u015fanacak herhangi bir aksama hisseyi \u00e7\u00f6kertebilir<\/li> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Gelecek \u00e7al\u0131\u015fmalar erken ba\u015far\u0131y\u0131 tekrarlamayabilir<\/li> <li><strong>Mali istikrars\u0131zl\u0131k<\/strong>: <a href=\"https:\/\/stockinvest.us\/stock\/MDGL\">-17,84 negatif EPS<\/a> ve nakit yak\u0131m\u0131<\/li> <li><strong>Rekabet<\/strong>: Di\u011fer \u015firketlerin MASH tedavileri geli\u015ftirmesi<\/li> <li><strong>Volatilite<\/strong>: %12,08 g\u00fcnl\u00fck dalgalanmalar yat\u0131r\u0131mc\u0131lar\u0131n sinirlerini zorlayabilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi<\/strong>: 2. \u00e7eyrekte y\u0131ll\u0131k %1.313 art\u0131\u015f<\/li> <li><strong>Pazar liderli\u011fi<\/strong>: \u0130lk ve tek FDA onayl\u0131 MASH tedavisi<\/li> <li><strong>Patent korumas\u0131<\/strong>: 2045 y\u0131l\u0131na kadar g\u00fcvence alt\u0131nda<\/li> <li><strong>Avrupa geni\u015flemesi<\/strong>: Olumlu CHMP g\u00f6r\u00fc\u015f\u00fc al\u0131nd\u0131<\/li> <li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 802 milyon $ nakit rezervi<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5'inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Ortalama maliyetle al\u0131m yap\u0131n<\/strong> - T\u00fcm yat\u0131r\u0131m\u0131 tek seferde de\u011fil, par\u00e7a par\u00e7a al\u0131n<\/li> <li><strong>Stop-loss koyun<\/strong> - Felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li> <li><strong>30 Ekim'i takip edin<\/strong> - 3. \u00e7eyrek kazan\u00e7lar\u0131 ivmeyi belirleyebilir<\/li> <\/ol> <p>Espiri: \"MDGL ticareti, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014inan\u0131lmaz potansiyel ama dramatik ruh hali dalgalanmalar\u0131na a\u00e7\u0131k. Tutarl\u0131 sonu\u00e7lar g\u00f6rene kadar kalbinizi ve ruhunuzu yat\u0131rmay\u0131n!\"<\/p> <h2>\u2705 Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ eri\u015fimi ve biyoteknoloji hisseleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>MDGL'yi detayl\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Riskleri ve potansiyel \u00f6d\u00fclleri anlay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Limitli emir verin<\/td><td>A\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td><\/tr> <tr><td>5<\/td><td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td><td>Biyoteknoloji aktif y\u00f6netim gerektirir, unutup b\u0131rakmak olmaz<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2> <p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> - Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto ve e-c\u00fczdanlar dahil 100'den fazla y\u00f6ntem<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> - Karma\u015f\u0131k biyoteknoloji hisselerinde yeni ba\u015flayanlar i\u00e7in ideal<\/li> <\/ul> <h2>\ud83c\udf0d Madrigal 2025'te: Karaci\u011fer Devriminin Lideri<\/h2> <p>Madrigal Pharmaceuticals, milyonlarca ki\u015fiyi etkileyen bu durum i\u00e7in FDA onayl\u0131 ilk tedavi olan Rezdiffra ile y\u00fckselen MASH tedavi pazar\u0131nda hakimiyet kuruyor. \u015eirketin <a href=\"https:\/\/www.stocktitan.net\/news\/MDGL\/madrigal-pharmaceuticals-reports-second-quarter-2025-financial-nfkrg4mm56mr.html\">2025 2. \u00e7eyrek sonu\u00e7lar\u0131 muhte\u015fem b\u00fcy\u00fcme<\/a> g\u00f6sterdi; 212,8 milyon $ gelir ve 23.000'den fazla hasta tedavi g\u00f6rd\u00fc.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Madrigal'in genel merkezi, \u00e7al\u0131\u015fan dinlenme odalar\u0131na ger\u00e7ek zamanl\u0131 karaci\u011fer sa\u011fl\u0131\u011f\u0131 izleme istasyonlar\u0131 kuran ilk biyoteknoloji \u015firketi oldu\u2014\u00e7al\u0131\u015fanlara \u00fccretsiz FibroScan testleri sunarak karaci\u011fer hastal\u0131klar\u0131 fark\u0131ndal\u0131\u011f\u0131na ba\u011fl\u0131l\u0131klar\u0131n\u0131 g\u00f6sterdi!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 MDGL Hisse Senedi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla Madrigal Pharmaceuticals (MDGL) <strong>302,17 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu biyoteknoloji harikas\u0131n\u0131 izleyen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir an. Ancak takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle \u00e7ok \u00f6nemli. \u00c7\u00fcnk\u00fc MDGL, 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayacak ve ge\u00e7mi\u015fte bu raporlar b\u00fcy\u00fck etkiler yaratm\u0131\u015ft\u0131r.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 MDGL Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>5 A\u011fustos 2025&#8217;teki son kazan\u00e7 raporu piyasada \u015fok etkisi yaratt\u0131. \u015eirket, <a href=\"https:\/\/www.nasdaq.com\/articles\/madrigal-mdgl-q2-revenue-soars-1313\">2. \u00e7eyrek gelirinin y\u0131ll\u0131k bazda %1.313 artarak<\/a> 212,8 milyon dolara ula\u015ft\u0131\u011f\u0131n\u0131 bildirdi ve tahminleri %31,3 a\u015farak ezdi. Hisse senedi, \u00f6nceki aylarda 275-302 $ aral\u0131\u011f\u0131ndan A\u011fustos ortas\u0131nda neredeyse 370 $ seviyesine kadar dramatik bir ivme kazand\u0131.<\/p>\n<p>Son haber olaylar\u0131n\u0131n MDGL \u00fczerindeki etkileri \u015f\u00f6yle:<\/p>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Etkisi<\/th>\n<th>S\u00fcre<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>17 Temmuz 2025<\/td>\n<td>Yeni patent korumas\u0131<\/td>\n<td>%11 art\u0131\u015f<\/td>\n<td>Tek g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>5 A\u011fustos 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131 beklentiyi a\u015ft\u0131<\/td>\n<td>%34 art\u0131\u015f<\/td>\n<td>2 hafta<\/td>\n<\/tr>\n<tr>\n<td>20 Haziran 2025<\/td>\n<td>Olumlu CHMP g\u00f6r\u00fc\u015f\u00fc<\/td>\n<td>%15 art\u0131\u015f<\/td>\n<td>3 g\u00fcn<\/td>\n<\/tr>\n<tr>\n<td>10 May\u0131s 2025<\/td>\n<td>Klinik deneme verileri<\/td>\n<td>%8 art\u0131\u015f<\/td>\n<td>1 hafta<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Desen a\u00e7\u0131k: olumlu d\u00fczenleyici ve klinik haberler patlay\u0131c\u0131 yukar\u0131 y\u00f6nl\u00fc potansiyel yarat\u0131yor. Ancak unutmay\u0131n\u2014biyoteknoloji hisseleri olumsuz geli\u015fmelerde ayn\u0131 h\u0131zla d\u00fc\u015febilir.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6 Ayl\u0131k Fiyat Yolculu\u011fu: Heyecan Dolu Dalgalanmalar<\/h2>\n<p>Madrigal Pharmaceuticals son alt\u0131 ayda nefes kesici bir performans sergiledi:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 202-220 $ (tatil sonras\u0131 konsolidasyon)<br \/> <strong>Mart 2025<\/strong>: 240-260 $ (Avrupa d\u00fczenleyici ilerlemesi)<br \/> <strong>May\u0131s 2025<\/strong>: 275 $ (istikrarl\u0131 y\u00fckseli\u015f)<br \/> <strong>Temmuz 2025<\/strong>: 302 $ (patent haberlerinin etkisi)<br \/> <strong>A\u011fustos 2025<\/strong>: 370 $ zirve (kazan\u00e7 patlamas\u0131)<\/p>\n<p>Bu, \u015eubat diplerinden A\u011fustos zirvelerine <strong>%75&#8217;ten fazla kazan\u00e7<\/strong> demek! Hisse, dramatik dalgalanmalarla <a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDGL\/\">%12,08 volatilite<\/a> g\u00f6sterdi ve yat\u0131r\u0131mc\u0131lara hem f\u0131rsatlar hem de stres yaratt\u0131.<\/p>\n<p>Bu b\u00fcy\u00fck y\u00fckseli\u015fin nedenleri?<\/p>\n<ul>\n<li>Rezdiffra&#8217;n\u0131n FDA onayl\u0131 ilk MASH tedavisi olmas\u0131<\/li>\n<li>Haziran 2025 itibar\u0131yla 23.000&#8217;den fazla hastan\u0131n tedavi g\u00f6rmesi<\/li>\n<li>Avrupa geni\u015flemesinin h\u0131zl\u0131 ilerlemesi<\/li>\n<li>2045 y\u0131l\u0131na kadar yeni patent korumas\u0131<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Mevcut analist projeksiyonlar\u0131 ve \u015firketin seyri g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, gelecekte \u015funlar olabilir:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 350-400 $ (ticari yay\u0131l\u0131m ba\u015far\u0131s\u0131n\u0131n devam\u0131) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><br \/> <strong>2026<\/strong>: 450-550 $ (Avrupa pazar penetrasyonunun h\u0131zlanmas\u0131)<br \/> <strong>2028<\/strong>: 700-900 $ (k\u00fcresel geni\u015fleme ve yeni \u00fcr\u00fcn hatt\u0131 geli\u015fmeleri)<br \/> <strong>2030<\/strong>: 1.200+ $ (karaci\u011fer hastal\u0131klar\u0131 tedavisinde pazar liderli\u011fi)<\/p>\n<p><a href=\"https:\/\/stockanalysis.com\/stocks\/mdgl\/forecast\/\">Analist konsens\u00fcs\u00fc<\/a> &#8220;G\u00fc\u00e7l\u00fc Al&#8221; derecesiyle olduk\u00e7a olumlu ve ortalama fiyat hedefi 439,71 $ seviyesinde. Ancak baz\u0131 modeller daha temkinli hedefler olan 229-275 $ aral\u0131\u011f\u0131n\u0131 \u00f6ng\u00f6r\u00fcyor, bu da biyoteknoloji de\u011ferlemelerindeki a\u015f\u0131r\u0131 belirsizli\u011fi g\u00f6steriyor.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>FDA d\u00fczenleyici riski<\/strong>: Onaylarda ya\u015fanacak herhangi bir aksama hisseyi \u00e7\u00f6kertebilir<\/li>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Gelecek \u00e7al\u0131\u015fmalar erken ba\u015far\u0131y\u0131 tekrarlamayabilir<\/li>\n<li><strong>Mali istikrars\u0131zl\u0131k<\/strong>: <a href=\"https:\/\/stockinvest.us\/stock\/MDGL\">-17,84 negatif EPS<\/a> ve nakit yak\u0131m\u0131<\/li>\n<li><strong>Rekabet<\/strong>: Di\u011fer \u015firketlerin MASH tedavileri geli\u015ftirmesi<\/li>\n<li><strong>Volatilite<\/strong>: %12,08 g\u00fcnl\u00fck dalgalanmalar yat\u0131r\u0131mc\u0131lar\u0131n sinirlerini zorlayabilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesi<\/strong>: 2. \u00e7eyrekte y\u0131ll\u0131k %1.313 art\u0131\u015f<\/li>\n<li><strong>Pazar liderli\u011fi<\/strong>: \u0130lk ve tek FDA onayl\u0131 MASH tedavisi<\/li>\n<li><strong>Patent korumas\u0131<\/strong>: 2045 y\u0131l\u0131na kadar g\u00fcvence alt\u0131nda<\/li>\n<li><strong>Avrupa geni\u015flemesi<\/strong>: Olumlu CHMP g\u00f6r\u00fc\u015f\u00fc al\u0131nd\u0131<\/li>\n<li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 802 milyon $ nakit rezervi<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir Yat\u0131r\u0131mc\u0131 Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5&#8217;inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Ortalama maliyetle al\u0131m yap\u0131n<\/strong> &#8211; T\u00fcm yat\u0131r\u0131m\u0131 tek seferde de\u011fil, par\u00e7a par\u00e7a al\u0131n<\/li>\n<li><strong>Stop-loss koyun<\/strong> &#8211; Felaket d\u00fc\u015f\u00fc\u015flere kar\u015f\u0131 kendinizi koruyun<\/li>\n<li><strong>30 Ekim&#8217;i takip edin<\/strong> &#8211; 3. \u00e7eyrek kazan\u00e7lar\u0131 ivmeyi belirleyebilir<\/li>\n<\/ol>\n<p>Espiri: &#8220;MDGL ticareti, dahi bir bilim insan\u0131yla \u00e7\u0131kmak gibidir\u2014inan\u0131lmaz potansiyel ama dramatik ruh hali dalgalanmalar\u0131na a\u00e7\u0131k. Tutarl\u0131 sonu\u00e7lar g\u00f6rene kadar kalbinizi ve ruhunuzu yat\u0131rmay\u0131n!&#8221;<\/p>\n<h2>\u2705 Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ eri\u015fimi ve biyoteknoloji hisseleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>MDGL&#8217;yi detayl\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Riskleri ve potansiyel \u00f6d\u00fclleri anlay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Limitli emir verin<\/td>\n<td>A\u015f\u0131r\u0131 \u00f6deme yapmamak i\u00e7in maksimum al\u0131\u015f fiyat\u0131n\u0131z\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Yat\u0131r\u0131m\u0131n\u0131z\u0131 takip edin<\/td>\n<td>Biyoteknoloji aktif y\u00f6netim gerektirir, unutup b\u0131rakmak olmaz<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Uygun?<\/h2>\n<p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; Stratejileri d\u00fc\u015f\u00fck riskle test edin<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Tek belge KYC ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto ve e-c\u00fczdanlar dahil 100&#8217;den fazla y\u00f6ntem<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong> &#8211; Karma\u015f\u0131k biyoteknoloji hisselerinde yeni ba\u015flayanlar i\u00e7in ideal<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Madrigal 2025&#8217;te: Karaci\u011fer Devriminin Lideri<\/h2>\n<p>Madrigal Pharmaceuticals, milyonlarca ki\u015fiyi etkileyen bu durum i\u00e7in FDA onayl\u0131 ilk tedavi olan Rezdiffra ile y\u00fckselen MASH tedavi pazar\u0131nda hakimiyet kuruyor. \u015eirketin <a href=\"https:\/\/www.stocktitan.net\/news\/MDGL\/madrigal-pharmaceuticals-reports-second-quarter-2025-financial-nfkrg4mm56mr.html\">2025 2. \u00e7eyrek sonu\u00e7lar\u0131 muhte\u015fem b\u00fcy\u00fcme<\/a> g\u00f6sterdi; 212,8 milyon $ gelir ve 23.000&#8217;den fazla hasta tedavi g\u00f6rd\u00fc.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Madrigal&#8217;in genel merkezi, \u00e7al\u0131\u015fan dinlenme odalar\u0131na ger\u00e7ek zamanl\u0131 karaci\u011fer sa\u011fl\u0131\u011f\u0131 izleme istasyonlar\u0131 kuran ilk biyoteknoloji \u015firketi oldu\u2014\u00e7al\u0131\u015fanlara \u00fccretsiz FibroScan testleri sunarak karaci\u011fer hastal\u0131klar\u0131 fark\u0131ndal\u0131\u011f\u0131na ba\u011fl\u0131l\u0131klar\u0131n\u0131 g\u00f6sterdi!<\/p>\n"},"faq":[{"question":"Madrigal Pharmaceuticals hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, MDGL hakk\u0131nda ara\u015ft\u0131rma yap\u0131n, limitli emir verin ve yat\u0131r\u0131m\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"MDGL hissesinin riskleri nelerdir?","answer":"FDA onay s\u00fcre\u00e7leri, klinik deneme sonu\u00e7lar\u0131, finansal durum, rekabet ve y\u00fcksek volatilite gibi riskler bulunmaktad\u0131r."},{"question":"MDGL hissesi i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin \u00e7o\u011funlu\u011fu 2025 sonunda 350-400 $ aral\u0131\u011f\u0131nda g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f bekliyor, uzun vadede ise 2030'da 1.200 $ ve \u00fczeri hedefleniyor."},{"question":"Yeni ba\u015flayanlar MDGL hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmak, kademeli al\u0131m yapmak, stop-loss kullanmak ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmek \u00f6nemlidir."},{"question":"Pocket Option biyoteknoloji yat\u0131r\u0131m\u0131 i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Madrigal Pharmaceuticals hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir arac\u0131 kurum veya online ticaret platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, MDGL hakk\u0131nda ara\u015ft\u0131rma yap\u0131n, limitli emir verin ve yat\u0131r\u0131m\u0131n\u0131z\u0131 d\u00fczenli olarak takip edin."},{"question":"MDGL hissesinin riskleri nelerdir?","answer":"FDA onay s\u00fcre\u00e7leri, klinik deneme sonu\u00e7lar\u0131, finansal durum, rekabet ve y\u00fcksek volatilite gibi riskler bulunmaktad\u0131r."},{"question":"MDGL hissesi i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin \u00e7o\u011funlu\u011fu 2025 sonunda 350-400 $ aral\u0131\u011f\u0131nda g\u00fc\u00e7l\u00fc bir y\u00fckseli\u015f bekliyor, uzun vadede ise 2030'da 1.200 $ ve \u00fczeri hedefleniyor."},{"question":"Yeni ba\u015flayanlar MDGL hissesi al\u0131rken nelere dikkat etmeli?","answer":"Portf\u00f6y\u00fcn k\u00fc\u00e7\u00fck bir k\u0131sm\u0131n\u0131 ay\u0131rmak, kademeli al\u0131m yapmak, stop-loss kullanmak ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmek \u00f6nemlidir."},{"question":"Pocket Option biyoteknoloji yat\u0131r\u0131m\u0131 i\u00e7in neden \u00f6nerilir?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7ok say\u0131da para \u00e7ekme se\u00e7ene\u011fi ve kullan\u0131c\u0131 dostu aray\u00fcz\u00fc ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in uygundur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T12:16:10+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T12:16:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\",\"name\":\"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-20T12:16:10+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","og_locale":"tr_TR","og_type":"article","og_title":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T12:16:10+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T12:16:10+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","name":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-20T12:16:10+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340663,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Madrigal Pharmaceuticals, Inc. (MDGL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":340667,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Madrigal Pharmaceuticals, Inc. (MDGL) - Investimento em a\u00e7\u00f5es da Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340664","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340664"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340664\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340664"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340664"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340664"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}